Glemser
Modernizing Regulatory Documentation in Pharmaceuticals

The demand for digital, standardized, and interoperable regulatory documentation has intensified in the intricate tapestry of the life sciences and regulatory compliance. It is the backbone of ensuring product quality, patient safety, efficiency, and compliance with stringent industry standards.

With an acute understanding of the current landscape, technology-enabled service provider Glemser Technologies is poised to address the regulatory content evolution by leveraging automation to reduce content generation timelines for life sciences and other regulated industries.

“Companies seek solutions to navigate the complexities of clinical labeling, global labeling, ePI (electronic product information) conversion, and the critical shift from outdated on-premise GxP (Good x Practice) systems to the dynamic realm of SaaS cloud-based infrastructure,” says Kevin Morgan, CEO of Glemser. “Amidst these challenges, the need to streamline and expedite regulatory content generation timelines has become a focal point, prompting a quest for automated, innovative, customer-centric solutions.”

Since updating obsolete technology processes and resources requires an enhanced solution, Glemser uses AI-powered structured content authoring to bridge this gap.

Glemser leverages natural language technologies to securely analyze customer data repositories and file shares to comprehend the content and context of various file types, creating structure from unstructured content. This produces structured content by reducing manual errors and risks to increase overall accuracy, marking a significant shift toward improved efficiency and compliance.

“One of the significant challenges we’re seeing clients looking to resolve is the need to move faster. Generating a clinical label can take up to four weeks, and a global label can take several months or even over a year to generate,” says Jamie Morisco, director of sales at Glemser. “We help implement a streamlined solution using ComplianceAuthor AI that reduces this timeline from months or weeks to days.”

At the heart of Glemser's offerings is ComplianceAuthor AI, a cloud-based SaaS solution that simplifies the content generation timeline by up to 50 percent, which is critical in product approval, patient safety, and quality. It is an AI-powered structured content authoring system that is GxP compliant, saving time, improving quality, reducing cost, and sustaining compliance.

ComplianceAuthor AI ensures widespread adoption and minimal end-user training since it leverages a user-friendly interface anchored in Microsoft Word technology. Its unique features, such as side-by-side document comparison and on-the-fly impact assessment, set it apart in the competitive landscape.

ComplianceAuthor AI accelerates the regulatory content generation process, making it less manual and time-consuming via its automated content management, but it also keeps a human in the loop to approve the outputs and next steps. The system also simplifies the review of documents through side-by-side redline comparison, reducing time spent formatting and associated errors made. Its component management system facilitates updates and assessments, streamlining complex data structures.

The agency-neutral format employed by ComplianceAuthor AI is a testament to Glemser's commitment to simplification and flexibility. This format allows clients to tailor configurations to their specific therapeutic areas, ensuring compatibility with regulatory submission standards, and provides clients with out-of-the-box pick lists, dropdown menus, and the different combinations needed to organize their data.

This allows clients to harmonize and swiftly navigate the business processes with the ability to add their specific product configurations. The format is designed for quality and regulatory purposes and contains complete audit trail support, making it a highly controlled and compliant system.

Glemser is dedicated to helping clients through various means, including using the ePI as a managed service, which takes a holistic approach by examining the business processes that support these activities, including labeling and changes.

Glemser also offers post-production support to ensure that its clients' systems and applications function correctly, delivered by its team of technical and functional experts located globally.

The brilliance of Glemser is evident through its clients' success stories. For instance, it assisted a multinational pharmaceutical and biotechnology giant in implementing a clinical labeling system, reducing their labeling timeline from four weeks to just a few days. This transformation emphasizes the efficiency gains achieved using Compliance Author AI.

Another example is its collaboration with a German pharmaceutical company. Glemser provided a system supporting their CMC (chemistry, manufacturing, and controls) quality processes, ensuring that their products are standard to meet patient safety guidelines and are consistent in human and animal use. These case studies portray how Glemser's solutions have elevated regulatory content management for pharmaceutical leaders.

The company also offers its clients the highest levels of data security by adhering to general data protection regulation (GDPR) and information security guidelines and maintaining a single-tenant security environment for maximum safety. Keeping patient data anonymous and limiting access to the system helps Glemser maintain the confidentiality and integrity of sensitive information.

Glemser offers transformative solutions to optimize content management in the pharmaceutical industry using its tested and proven AI tools, enabling efficiency and compliance and making it a trusted partner for companies seeking to navigate the challenging compliance landscape. It is not just a technology provider but a catalyst for industry progress, setting a new standard for regulatory documentation in the pharmaceutical sector.